Biocomposites invests in Renovos Biologics – develope

Biocomposites invests in Renovos Biologics – developers of the RENOVITE® nanoclay therapeutic delivery platform

Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for regenerating bone and managing infection in bone and soft tissue, today announces it has taken a minority-share interest in Renovos Biologics (Renovos), an innovative biologics company born ...

Related Keywords

United Kingdom , Renovos Biologics , Michael Harris , Agnieszka Janeczek , University Of Southampton , Renovos Biologics Board , Chief Executive Officer ,

© 2024 Vimarsana